Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

Similar articles for PubMed (Select 24471611)

1.

Help to ease the pain.

Mayor S.

Nurs Stand. 2014 Jan 29-Feb 4;28(22):25. doi: 10.7748/ns2014.01.28.22.25.s28.

PMID:
24471611
2.

Practice nurses praised for shingles jab uptake.

[No authors listed]

Nurs Times. 2014 Dec 10-16;110(50):5. No abstract available.

PMID:
26021043
3.

Introduction of a national herpes zoster (shingles) immunization programme and impact on neuropathic pain.

Murdoch H, Potts A, Colvin L, Cameron JC, Pollock KG.

Eur J Pain. 2014 Sep;18(8):1217-8. doi: 10.1002/j.1532-2149.2014.495.x. No abstract available.

PMID:
25139819
4.

Vaccines for preventing herpes zoster in older adults.

Leme LE.

Sao Paulo Med J. 2014;132(4):255. No abstract available.

5.

Immunisation for herpes zoster: current status.

Cunningham AL, Litt JC, Macintyre CR.

Med J Aust. 2014 Mar 17;200(5):243-4. No abstract available.

PMID:
24641130
6.

Herpes zoster ophthalmicus reduction: implementation of shingles vaccination in the UK.

Potts A, Williams GJ, Olson JA, Pollock KG, Murdoch H, Cameron JC.

Eye (Lond). 2014 Mar;28(3):247-8. doi: 10.1038/eye.2013.303. No abstract available.

7.

[The clinical and epidemic characteristics of shingles (herpes zoster) and its prevention with vaccines].

Afonina NM, Mikheeva IV.

Ter Arkh. 2013;85(11):130-3. Review. Russian.

PMID:
24432613
8.

Prevention of herpes zoster in older adults.

Kocher J.

Am Fam Physician. 2013 Nov 1;88(9):578. No abstract available.

9.

Herpes zoster: diagnostic, therapeutic, and preventive approaches.

Bader MS.

Postgrad Med. 2013 Sep;125(5):78-91. doi: 10.3810/pgm.2013.09.2703. Review.

PMID:
24113666
10.

Zostavax : a subcutaneous vaccine for the prevention of herpes zoster.

Doan HQ, Ung B, Ramirez-Fort MK, Khan F, Tyring SK.

Expert Opin Biol Ther. 2013 Oct;13(10):1467-77. doi: 10.1517/14712598.2013.830101. Epub 2013 Aug 29.

PMID:
23984934
11.
12.

Zoster vaccine protects against shingles.

[No authors listed]

BMJ. 2013 Apr 17;346:f2389. doi: 10.1136/bmj.f2389. No abstract available.

PMID:
23596220
13.

Herpes zoster vaccine effectiveness against incident herpes zoster and post-herpetic neuralgia in an older US population: a cohort study.

Langan SM, Smeeth L, Margolis DJ, Thomas SL.

PLoS Med. 2013;10(4):e1001420. doi: 10.1371/journal.pmed.1001420. Epub 2013 Apr 9.

14.

Vaccine against herpes zoster halves incidence in older people, finds study.

Ramsey S.

BMJ. 2013 Apr 12;346:f2349. doi: 10.1136/bmj.f2349. No abstract available.

PMID:
23585074
15.

Vaccine against herpes zoster.

Pasternak J.

Einstein (Sao Paulo). 2013 Jan-Mar;11(1):133-4. English, Portuguese.

16.

TNF antagonists and shingles: is vaccination advisable?

Nisar MK, Ostor AJ.

Ann Rheum Dis. 2013 May;72(5):e1. doi: 10.1136/annrheumdis-2013-203389. Epub 2013 Mar 1. No abstract available.

PMID:
23456927
17.

Vaccination of older adults against herpes zoster is safe and effective.

Tyring SK.

Evid Based Med. 2013 Oct;18(5):e43. doi: 10.1136/eb-2012-101138. Epub 2013 Feb 16. No abstract available.

PMID:
23416421
18.

Herpes zoster vaccine. Poorly effective in those who need it most.

[No authors listed]

Prescrire Int. 2012 Dec;21(133):291.

PMID:
23373094
19.

A systematic review of the cost effectiveness of herpes zoster vaccination.

Szucs TD, Pfeil AM.

Pharmacoeconomics. 2013 Feb;31(2):125-36. doi: 10.1007/s40273-012-0020-7. Review.

PMID:
23335045
20.

Cost-effectiveness of vaccination of the elderly against herpes zoster in The Netherlands.

de Boer PT, Pouwels KB, Cox JM, Hak E, Wilschut JC, Postma MJ.

Vaccine. 2013 Feb 18;31(9):1276-83. doi: 10.1016/j.vaccine.2012.12.067. Epub 2013 Jan 8.

PMID:
23306360
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk